Vipera ursinii venom protein toxins

Vipera ursinii venom protein toxins represent a complex mixture of bioactive proteins and peptides secreted by the Meadow Viper, primarily used for prey immobilization and digestion (Latinović et al., 2020, Toxins). The venom is characterized by a high concentration of phospholipase A2 (PLA2) enzymes, snake venom metalloproteinases (SVMPs), and serine proteases, which collectively induce local tissue damage, edema, and systemic hematological disturbances (Malina et al., 2017, Journal of Proteomics). While generally considered less toxic than other European vipers like Vipera ammodytes, envenomation can lead to significant morbidity, including hemorrhage and inflammatory complications (Bocian et al., 2016, Toxicon). In a clinical context, these toxins serve as the primary targets for polyvalent antivenom therapies, such as the European Viper Venom Antiserum, which utilize purified antibodies to neutralize the venom's enzymatic activities (World Health Organization, 2016). Understanding the specific proteomic profile of Vipera ursinii is crucial for developing effective regional antivenoms and managing snakebite victims (Saviola et al., 2015, Toxicon).

Other names

Meadow viper venomOrsini's viper venomVipera ursinii toxinsVipera ursinii venom

Neutralization of toxic enzymatic and non-enzymatic proteins through antibody-mediated binding, preventing interaction with host substrates and receptors.